Medical News

RSS

BioSpecifics reports $0.3M net income for third quarter 2011 vs. $0.5M net loss for third quarter 2010

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe today announced its financial results for the third quarter ended September 30, 2011 and provided a corporate update. For the quarter, the Company reported net income of $0.3 million or $0.04 per share on a basic and on a fully diluted basis.

9 Nov 2011

Micromet's blinatumomab data to be reported at 53rd ASH annual meeting

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab (MT103) will be reported at the 53rd Annual American Society of Hematology (ASH) Annual Meeting, to be held December 10 - 13 in San Diego, California.

9 Nov 2011

Boston Scientific reports positive long-term data from PERSEUS clinical program

Boston Scientific Corporation reports positive long-term data from the PERSEUS clinical program, which demonstrated favorable two-year safety and effectiveness outcomes for the ION (TAXUS Element) Paclitaxel-Eluting Platinum Chromium Stent System versus prior-generation paclitaxel-eluting stents.

9 Nov 2011

Political cartoon: 'Super Trapped?'

Kaiser Health News provides a fresh take on health policy developments with "Super Trapped?" by Steve Kelley.

9 Nov 2011

'Second hit' determines immune response against developing Burkitt's lymphoma

The human c-myc gene encodes a transcription factor (MYC) involved in the regulation of a vast number of other genes - it has been estimated that the transcription of about one in six genes is somehow under the control of MYC.

9 Nov 2011

Global Fund delays closing date for round 11 applications, says disbursements may not be available until 2013

The Global Fund to Fight HIV, TB and Malaria has delayed the closing date for applications for its next round of funding, reduced the estimated amount of money that will be available in that round, and potentially delayed the disbursement of the funds until 2013, PlusNews reports.

9 Nov 2011

Fluidigm third quarter total revenue increases 25% to $10.6 million

Fluidigm Corporation today announced its financial results for the third quarter ended September 30, 2011.

9 Nov 2011

Scripps scientist receives Novo Nordisk grant for research into diabetes

Andrew Butler, an associate professor in The Scripps Research Institute's Department of Metabolism and Aging, has been awarded one million dollars in funding over the next two years to further his research into a novel protein with the potential to improve the understanding and future treatment of diabetes.

9 Nov 2011

RNS system offers significant relief to patients with intractable seizures

Brain stimulation, already approved by the U.S. Food and Drug Administration for the treatment of Parkinson's disease and essential tremor, has now been shown to offer significant relief to patients with intractable seizures for whom drugs and other treatments have not worked.

9 Nov 2011

Inova Labs secures $17.5M in Series B round of equity financing

Inova Labs, a privately held medical device company focused on developing innovative products for the Chronic Obstructive Pulmonary Disease (COPD) market, announced today that it has secured a Series B round of equity financing for up to $17.5M from an investment syndicate led by Latterell Venture Partners, based in San Francisco, Calif.

9 Nov 2011

Clinton expected to urge U.S., other countries to intensify HIV/AIDS prevention efforts in speech on Tuesday

In a speech to be delivered at the NIH, "Secretary of State Hillary Clinton is expected to call Tuesday for a new push by the U.S. and other countries to harness recent science to stem the HIV/AIDS pandemic," the Wall Street Journal reports.

9 Nov 2011

ScreenCell, Transgenomic sign collaboration and distribution agreement for CTC technology

Transgenomic, Inc. and ScreenCell, a privately-held company, today announced the signing of a perpetual, worldwide collaboration and distribution agreement for ScreenCell's Isolation Devices and Dilution Buffers, designed for the collection of Circulating Tumor Cells (CTCs) in peripheral blood.

9 Nov 2011

DFINE closes $25 million round of equity financing

DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, announced today the closing of a $25 million round of equity financing.

9 Nov 2011

Powerful monitoring tool to track spread of seasonal flu

A powerful monitoring tool that will allow researchers to track the spread of seasonal flu launches today. This year the UK Flusurvey will, for the first time, join a European network of online surveys, gathering information on how the illness spreads across the continent and enabling comparison between the different countries.

9 Nov 2011

Accuray reports total consolidated GAAP revenue of $100.5 million for first quarter 2012

Accuray Incorporated, the premier radiation oncology company, announced today financial results for the first quarter of fiscal 2012 that ended September 30, 2011.

9 Nov 2011

Hospitals face penalties if they don't please patients

In the coming months, Medicare will start taking patient satisfaction into account when reimbursing hospitals.

9 Nov 2011

State roundup: Kansas Medicaid announcement; pilot projects for nursing homes, C-sections; Calif. marijuana clinics

Gov. Sam Brownback, Lt. Gov. Jeff Colyer and three Cabinet officials have scheduled a news conference for 10 a.m. Tuesday to describe details of their plan for making over the Kansas Medicaid program. ... The plan is expected to include a significant expansion of managed care.

9 Nov 2011

Low uptake of screening and poor awareness of breast cancer symptoms need to be addressed

Fear, anxiety and embarrassment are some of the main barriers preventing women from going for breast screening, but this alone does not account for the variations in uptake, according to new work presented today at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today.

9 Nov 2011

Electromed first quarter net revenues increase 29.1% to $5.38 million

Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.

8 Nov 2011

Kessler Foundation neuropsychologists receive National Multiple Sclerosis Society grants

Two neuropsychologists at Kessler Foundation Research Center were awarded more than $100,000 in grants by the National Multiple Sclerosis Society. Nancy Chiaravalloti, PhD, received $63,000 to conduct a pilot study, "Speed of Processing Training for Improving Processing Speed in Persons with MS".

8 Nov 2011

Medical News

BioSpecifics reports $0.3M net income for third quarter 2011 vs. $0.5M net loss for third quarter 2010

Micromet's blinatumomab data to be reported at 53rd ASH annual meeting

Boston Scientific reports positive long-term data from PERSEUS clinical program

Political cartoon: 'Super Trapped?'

'Second hit' determines immune response against developing Burkitt's lymphoma

Global Fund delays closing date for round 11 applications, says disbursements may not be available until 2013

Fluidigm third quarter total revenue increases 25% to $10.6 million

Scripps scientist receives Novo Nordisk grant for research into diabetes

RNS system offers significant relief to patients with intractable seizures

Inova Labs secures $17.5M in Series B round of equity financing

Clinton expected to urge U.S., other countries to intensify HIV/AIDS prevention efforts in speech on Tuesday

ScreenCell, Transgenomic sign collaboration and distribution agreement for CTC technology

DFINE closes $25 million round of equity financing

Powerful monitoring tool to track spread of seasonal flu

Accuray reports total consolidated GAAP revenue of $100.5 million for first quarter 2012

Hospitals face penalties if they don't please patients

State roundup: Kansas Medicaid announcement; pilot projects for nursing homes, C-sections; Calif. marijuana clinics

Low uptake of screening and poor awareness of breast cancer symptoms need to be addressed

Electromed first quarter net revenues increase 29.1% to $5.38 million

Kessler Foundation neuropsychologists receive National Multiple Sclerosis Society grants

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News